Clinical research and care in the era of "N-of-1" precision cancer medicine

Get full text
Series

Design early phase drug combination trials software /

Get full text
Series

Metabolomics a brief introduction, part 1 of 2 /

Get full text
Series

FAIR data in metabolomics

Get full text
Series

Overview of clinical pharmacology in cancer part 2 of 2 /

Get full text
Series

Analysis of LCMS-based untargeted metabolomics data part 1 of 2 /

Get full text
Series

Metabolomics importance of experimental design to data acquisition, part 1 of 2 /

Get full text
Series

Gene-drives and active genetics introduction to gene-drives and their implications for health and society /

Get full text
Series

Data sharing and data standards for metabolomics where are we now? /

Get full text
Series

Data fusion examples in fusing metabolomics and transcriptomics data /

Get full text
Series

Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

Get full text
Series

The Salford lung study in COPD

Get full text
Series

Comparing transcriptomes of distant organisms models of gene expression, part 2 of 2 /

Get full text
Series

Adaptive clinical trials overview, part 2 of 2 /

Get full text
Series

Population modification of malaria vector mosquitoes

Get full text
Series

Metabolomics data analysis in the context of metabolic networks

Get full text
Series

Bridging our mandates evidence-based practice (EBP) and patient-centered care (PCC), part 2 of 2/

Get full text
Series

Design and conduct of non-inferiority trials

Get full text
Series (Risk of bias in randomized clinical trials)
Series (Design and analysis of randomized clinical trials)

Metabolomics resources

Get full text
Series

Public response to a proposed field trial of genetically engineered mosquitoes in the United States a case study /

Get full text
Series